Brokerages Set Intuitive Surgical, Inc. (NASDAQ:ISRG) Target Price at $581.91

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been given an average rating of “Moderate Buy” by the twenty-seven analysts that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, seven have given a hold rating and nineteen have given a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $579.3333.

Several equities analysts have recently commented on ISRG shares. Robert W. Baird upped their price target on Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Piper Sandler decreased their target price on shares of Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Argus decreased their target price on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research report on Wednesday, February 4th. Bank of America decreased their price objective on shares of Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a report on Monday. Finally, UBS Group decreased their price objective on shares of Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating on the stock in a report on Tuesday, March 17th.

Intuitive Surgical Trading Down 2.1%

Shares of ISRG opened at $439.80 on Friday. Intuitive Surgical has a 12 month low of $417.74 and a 12 month high of $603.88. The stock’s 50 day moving average is $459.71 and its two-hundred day moving average is $511.12. The firm has a market cap of $155.76 billion, a P/E ratio of 53.31, a PEG ratio of 3.58 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. Intuitive Surgical’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.81 earnings per share. Equities research analysts forecast that Intuitive Surgical will post 8.57 EPS for the current year.

Insider Activity

In related news, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $446.95, for a total transaction of $178,780.00. Following the transaction, the executive vice president owned 6,120 shares of the company’s stock, valued at approximately $2,735,334. This represents a 6.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Mark Brosius sold 2,362 shares of the stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total value of $1,177,882.16. Following the transaction, the senior vice president directly owned 3,554 shares in the company, valued at approximately $1,772,308.72. The trade was a 39.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 5,683 shares of company stock worth $2,775,891 in the last quarter. Insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Riversedge Advisors LLC raised its stake in Intuitive Surgical by 1.9% during the 4th quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock worth $510,000 after acquiring an additional 17 shares in the last quarter. Fiduciary Financial Group LLC raised its stake in Intuitive Surgical by 2.1% during the 4th quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock worth $521,000 after acquiring an additional 19 shares in the last quarter. Prosperity Consulting Group LLC raised its stake in Intuitive Surgical by 0.5% during the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after acquiring an additional 19 shares in the last quarter. Rossmore Private Capital raised its stake in Intuitive Surgical by 2.0% during the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after acquiring an additional 20 shares in the last quarter. Finally, Activest Wealth Management raised its stake in Intuitive Surgical by 21.7% during the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after acquiring an additional 20 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive announced new innovations aimed at improving its robotic surgery ecosystem, including enhanced telecollaboration, broader Force Feedback uses, and better reliability and security across da Vinci 5 and related products, which reinforces the company’s technology leadership. Article Title
• Positive Sentiment: Coverage highlighted strong early momentum in the SP platform, with Q1 2026 procedures up 68%, raising hopes that the platform could unlock new procedure growth and expand ISRG’s total addressable market. Article Title
• Positive Sentiment: Analysts and commentators continue to point to Intuitive Surgical as a long-term robotics leader, with interest centered on the rollout of the da Vinci 5 platform and its AI-enabled compute stack, supporting the bullish investment case. Article Title
• Neutral Sentiment: A Zacks piece revisited why ISRG has fallen since its last earnings report, but it did not introduce a new negative catalyst; it mainly reflects post-earnings digestion and valuation concerns. Article Title
• Neutral Sentiment: Two very small insider sales by EVP Mark Brosius were disclosed, but both were executed under a pre-arranged 10b5-1 plan and are unlikely to be meaningful on their own. Article Title
• Negative Sentiment: Some market commentary still frames medical-device stocks as under pressure, and broader sector weakness may be weighing on investor sentiment despite ISRG’s solid fundamentals.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.